# Sagar Sardesai, M.D., Columbus, OH – FDA Inspections

Source: https://www.keypedia.com/companies/sagar-sardesai-md/48fb6003-8be0-4ab0-bb9b-61893e4ca3e5

> Inspection records and compliance data for Sagar Sardesai, M.D. in Columbus, Ohio. 2 FDA inspections on record, last inspected January 20, 2026.

---

## Details

- Name: Sagar Sardesai, M.D.
- FEI Number: 3017666994
- Address Line 1: Ohio State Comprehensive Cancer Center, James Cancer Hospital, 241 W 11th Ave Ste 4055
- City: Columbus
- State: Ohio
- Zip Code: 43201
- Country Name: United States
- Address: Ohio State Comprehensive Cancer Center, James Cancer Hospital, 241 W 11th Ave Ste 4055, Columbus, Ohio 43201, United States
- Country: United States

## Related Documents

- FDA Inspection 1300484 - Sagar Sardesai, M.D. - 2026-01-20 — source: FDA, date: January 20, 2026
- FDA Inspection 1300484 - Sagar Sardesai, M.D. - 2026-01-20 — classification: No Action Indicated (NAI), source: FDA, date: January 20, 2026
- [483 - Sagar Sardesai, M.D. - 2021-02-12](https://www.keypedia.com/records/483/sagar-sardesai-md/f9d36c46-575a-4013-811f-f6de71041a70) — source: FDA, date: February 12, 2021
- [FDA Inspection 1135594 - Sagar Sardesai, M.D. - 2021-02-12](https://www.keypedia.com/records/fda_inspections/sagar-sardesai-md/61a004e4-9114-476a-9323-f75062c6d394) — classification: Voluntary Action Indicated (VAI), source: FDA, date: February 12, 2021

## Related Companies

- [RXQ Compounding LLC](https://www.keypedia.com/companies/rxq-compounding-llc/acf60274-80ce-4e6c-8ecf-25eed581d137)
- [Medpace Reference Laboratories](https://www.keypedia.com/companies/medpace-reference-laboratories/a7ee80f3-4a9b-4595-8184-6036a56becff)
- [Gipsco Investment Corp](https://www.keypedia.com/companies/gipsco-investment-corp/29265f19-8c03-46da-97aa-fd3ea30c57a9)
- [Charles River Laboratories Inc](https://www.keypedia.com/companies/charles-river-laboratories-inc/3bac9c8e-9e95-4a29-9ffd-ac0c78cd6ed2)
- [Bernadette D'Souza, MD](https://www.keypedia.com/companies/bernadette-dsouza-md/9320d19e-1a22-4927-8948-8d2a71d87dba)
- [Steven C. Kester, M.D.](https://www.keypedia.com/companies/steven-c-kester-md/60b88fd1-7b62-4f85-a516-f926428eaa1b)
- [Ahmed Kaldun Nossuli M.D., Principal Investigator](https://www.keypedia.com/companies/ahmed-kaldun-nossuli-md-principal-investigator/abed3af2-8f50-4693-99cf-ca14db6168d8)
- [inVentiv Health Clinical Lab, Inc.](https://www.keypedia.com/companies/inventiv-health-clinical-lab-inc/b0d471dc-05cc-4b3b-8fda-4ee2aa0a4cfa)
- [TAGI Pharma, Inc.](https://www.keypedia.com/companies/tagi-pharma-inc/0aa08a98-71bc-4918-b7f9-b38edd0a6224)
- [Cantrell Drug Company](https://www.keypedia.com/companies/cantrell-drug-company/898c7c22-1973-447f-a537-6abe91ebc1c9)

## Related Officers

- [investigator](https://www.keypedia.com/people/geoffrey-k-kilili/b00aeedf-95bd-4ccf-a23e-6e12e60249c4)